Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
Jaguar Health, Inc. (the "Company") filed this Current Report on Form 8-K on November 20, 2017. The filing serves to announce the Company's financial results for the third fiscal quarter ended September 30, 2017. The Company is incorporated in Delaware and identifies as an emerging growth company.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing references a press release (Exhibit 99.1) containing these details but does not reproduce the figures within the body of the 8-K text.
Material Changes
The filing text does not provide specific data regarding material changes in financial performance compared to the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information contained in this Form 8-K and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that Section or incorporated by reference into other filings, except as expressly set forth by specific reference. No specific guidance, outlook, or risk factors are detailed in the text of this report.
Key Facts for Investor Verification
- Verify the specific financial results for the quarter ended September 30, 2017, by reviewing Exhibit 99.1 (Press Release) attached to this filing.
- Confirm the Company's status as an emerging growth company and its election regarding the extended transition period for new accounting standards.
- Note that the financial data in this 8-K is not incorporated by reference into other SEC filings unless explicitly stated.